초록 ▼

The present invention provides an energy conversion composition which has an excellent capability of absorbing and damping energy such as dynamic, thermal, or electric energy. The composition can be made into a very thin and small but excellent damping product. The energy conversion composition is c

The present invention provides an energy conversion composition which has an excellent capability of absorbing and damping energy such as dynamic, thermal, or electric energy. The composition can be made into a very thin and small but excellent damping product. The energy conversion composition is characterized in that its base material contains a moment activator which can increase the amount of dipole moments in the base material. The energy conversion composition can be utilized as a vibration damping, sound absorptive, impact absorptive, vibration-proof, electromagnetic wave absorptive, piezoelectric, and endothermal material as well as a polarity liquid.

대표청구항 ▼

The present invention provides an energy conversion composition which has an excellent capability of absorbing and damping energy such as dynamic, thermal, or electric energy. The composition can be made into a very thin and small but excellent damping product. The energy conversion composition is c

The present invention provides an energy conversion composition which has an excellent capability of absorbing and damping energy such as dynamic, thermal, or electric energy. The composition can be made into a very thin and small but excellent damping product. The energy conversion composition is characterized in that its base material contains a moment activator which can increase the amount of dipole moments in the base material. The energy conversion composition can be utilized as a vibration damping, sound absorptive, impact absorptive, vibration-proof, electromagnetic wave absorptive, piezoelectric, and endothermal material as well as a polarity liquid. 31-37 (1992). ive lipid compound is selected from dipalmitoyl phosphatidic acid (DPPA), di-palmitoylglycerole (DPPG), oleyl amine and stearyl amine. 5. The liposome-based composition of claim 1, Wherein the buffer is selected from sodium dihydrogen phosphate dihydrate, di-sodium hydrogen phosphate dihydrate, and mixtures thereof. 6. The liposome-based composition of claim 1, characterized in that it father comprises a preserving agent. 7. The liposome-based composition of claim 1, characterized in that it tinter comprises an antioxidant. 8. The liposome-based composition of claim 1, characterized in that it has the following composition: TBL g/100 g Erythropoietin or its 200,000 U-1 Mill. Units pharmaceutically acceptable derivatives having the bio- logical properties of causing bone marrow cells to increase production of reticulocytes and red blood cells Lecithin hydrogenated (Soya) 0.5-5.000 Cholesterol 0.1-1.000 Charged lipid 0.05-0.5 Ethanol 0.5-5.000 Glycine 0.0-1.00 Buffer up to 2.0 Water q.s ad 100.0. 9. A method for treating anemia in a human in need of such treatment comprising administering a pharmaceutically effective amount of the liposome-based composition according to claim 1. 10. The liposome-based composition of claim 1, characterized in that it has the following composition: TBL g/100 g Erythropoietin 1 Million I.U. Lecithin (Soya) hydrogenated 0.500 Cholesterol 0.100 DPPA-Na 0.040 Ethanol Pharma Undenatured 0.500 Sodium Dihydrogenphosphate Dihydrate 0.1164 di-Sodium Hydrogen Phosphate Dihydrate 0.2225 Sodium Chloride 0.584 Water purified 97.9371